NIRvana Sciences Successfully Closes Series A

RESEARCH TRIANGLE PARK, NC, September 1st, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has successfully closed its Series A investment round. The oversubscribed round includes investments from many angel investments groups in North Carolina and South Carolina as well as some private angels.